{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:40:29Z","timestamp":1761964829449,"version":"3.44.0"},"reference-count":13,"publisher":"BMJ","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["RRAK17205"],"award-info":[{"award-number":["RRAK17205"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,11,4]]},"abstract":"<jats:p>A 46-year-old woman with a history of dasatinib-resistant chronic myeloid leukaemia, clonal evolution and monosomy 7 underwent reduced intensity conditioned in vivo T-cell-depleted allogeneic haematopoietic stem cell transplantation (HSCT) from a matched unrelated donor. Following the transplantation, she developed recurrent cutaneous graft versus host disease (GvHD), which required treatment with systemic immunosuppression and electrocorporeal photophoresis. Concurrently, she developed a lichenoid rash with granulomatous features suggestive of cutaneous sarcoidosis. Additional treatment with hydroxychloroquine was initially successful, but 2\u2005months later, she developed erythroderma with palpable lymphadenopathy. Repeated histological analysis established a diagnosis of folliculotropic mycosis fungoides stage IVA2, and the malignant clone was confirmed to be of donor origin. A positive response to brentuximab has been shown. This is the first reported case of primary mycosis fungoides after matched unrelated donor HSCT, and in a patient still undergoing treatment for GvHD.<\/jats:p>","DOI":"10.1136\/bcr-2016-216331","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T11:35:23Z","timestamp":1484048123000},"page":"bcr2016216331","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor"],"prefix":"10.1136","volume":"2017","author":[{"given":"Francesca A M","family":"Kinsella","sequence":"first","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Rasoul","family":"Amel Kashipaz","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Scarisbrick","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Malladi","sequence":"additional","affiliation":[{"name":"Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.38"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.60"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2011.08756.x","article-title":"Secondary cancers following allogeneic haematopoietic cell transplantation in adults","volume":"154","author":"Majhail","year":"2011","journal-title":"Br J Haematol"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010041"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03509.x"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.6","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.clml.2013.05.018","article-title":"Primary cutaneous gamma-delta T-cell lymphoma with marked pagetoid epidermotropism shortly after allogeneic stem cell transplantation","volume":"13","author":"Bautista-Quach","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3348\/kjr.2013.14.5.718","article-title":"Isolated post-transplantation lymphoproliferative disease involving the breast and axilla as peripheral T-cell lymphoma","volume":"14","author":"Hwang","year":"2013","journal-title":"Korean J Radiol"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.8","doi-asserted-by":"publisher","DOI":"10.1177\/0300060513507646"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/bjd.12647","article-title":"Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor","volume":"170","author":"Fahy","year":"2014","journal-title":"Br J Dermatol"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-142968"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199109053251007"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0899"},{"key":"2025082702314471000_2017.jan10_3.bcr2016216331.13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2230.2009.03475.x","article-title":"Extracorporeal photopheresis: what is it and when should it be used?","volume":"34","author":"Scarisbrick","year":"2009","journal-title":"Clin Exp Dermatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-216331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:31:55Z","timestamp":1756287115000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-216331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":13,"alternative-id":["10.1136\/bcr-2016-216331"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-216331","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2017,1,10]]}}}